Details and working sheet for common formulations under DPCO 1995 as well as DPCO 2013 where prices is fixed in April 2015
Source of data: companies
| NLEM Unique No. | Composition as per NLEM | PACK_DESC | BRANDS | Company | Strength | Pack size | Unit | MAT Sep’14 Value | MAT% | PTR Sep’14 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.5.3.1.2.2 | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | NIVAQUINE P 40 MG INJECTION 5 ML | Nivaquine | ABBOTT HEALTHCARE PVT. LTD | 40 | 5 | ML | 0.76 | 5.98% | 5.21 | 1.04 | -- |
| -- | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | NIVAQUINE P 40 MG INJECTION 2 ML | Nivaquine | ABBOTT HEALTHCARE PVT. LTD | 40 | 2 | ML | 0.55 | 4.32% | 3.32 | 1.66 | -- |
| -- | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | NIVAQUINE P 40 MG INJECTION 30 ML | Nivaquine | ABBOTT HEALTHCARE PVT. LTD | 40 | 30 | ML | 0.21 | 1.63% | 15.86 | 0.53 | -- |
| -- | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | LARIAGO 40 MG INJECTION 30 ML | -- | IPCA LABORATORIES PVT LTD. | 40 | 30 | ML | 8.06 | 63.58% | 17.01 | 0.57 | -- |
| -- | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | LARIAGO 40 MG INJECTION 5 ML | -- | IPCA LABORATORIES PVT LTD. | 40 | 5 | ML | 1.88 | 14.83% | 5.58 | 1.12 | -- |
| -- | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | LARIAGO 40 MG INJECTION 2 ML | -- | IPCA LABORATORIES PVT LTD. | 40 | 2 | ML | 0.51 | 4.02% | 3.55 | 1.78 | -- |
| -- | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | EMQUIN 40 MG INJECTION 30 ML | -- | MERCK LTD | 40 | 30 | ML | 0.71 | 5.64% | 15.52 | 0.52 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | 12.7 | 100.00% | -- | 1.03 | 1.19 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | maximum | 1.78 | minimum | 0.52 |
| -- | As per the above there are 3 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Sum of MAT value considered for price calculation | 1,268.00 | (Rs. in lak | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Sum of PTR per unit considered for price calculation | 7.22 | -- | -- |
-- | -- |
||||||
| -- | Number of Packs considered | 7 | -- | -- |
||||||||
| -- | Average PTR | 1.03 | -- | -- |
||||||||
| -- | Add : 16% Retailer Margin | 0.16 | -- | -- |
||||||||
| -- | Ceiling Price (without local taxes) | 1.19 | -- | -- |
||||||||
| -- | % Reduction with compared to Highest Price | 42.13% | -- | -- |
||||||||
| -- | -- | -- | -- | -- | -- | -- |
||||||
| -- | WPI increase on 1 April, 2014 | 6.32% | -- | -- |
||||||||
| -- | Ceiling Price after WPI Adjustment | 1.27 | -- | -- |
||||||||
| -- | WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
| -- | Ceiling Price after WPI Adjustment | 1.32 | -- |
-- | -- |
|||||||
Source of data: Pharma Trac and company
| NLEM Unique No. | Composition as per NLEM | PACK_DESC | BRANDS | Company | Strength | Pack size | Unit | MAT Sep’14 Value | MAT% | PTR Sep’14 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.2.2.8.1.1 | Metronidazole Tablet 200mg | FLAGYL 200 MG TABLET 15 | -- | ABBOTT HEALTHCARE PVT. LTD | 200 | 15 | Tablet | 1.95 | 22.18% | 5.53 | 0.37 | -- |
| -- | Metronidazole Tablet 200mg | METRON 200 MG TABLET 10 | -- | ALKEM LABORATORIES LTD. | 200 | 10 | Tablet | 0.31 | 3.57% | 3.62 | 0.36 | -- |
| -- | Metronidazole Tablet 200mg | METGYL 200 MG TABLET 100 | -- | JAGSONPAL PHARMACEUTICALS L | 200 | 100 | Tablet | 0.18 | 2.02% | 30.00 | 0.30 | -- |
| -- | Metronidazole Tablet 200mg | METROGYL 200 MG TABLET 15 | -- | JB CHEMICALS | 200 | 15 | Tablet | 4.30 | 48.90% | 5.53 | 0.37 | -- |
| -- | Metronidazole Tablet 200mg | METROGYL 200 MG TABLET 10 | -- | JB CHEMICALS | 200 | 10 | Tablet | 1.27 | 14.45% | 3.80 | 0.38 | -- |
| -- | Metronidazole Tablet 200mg | METROGYL 200 MG TABLET 100 | -- | JB CHEMICALS | 200 | 100 | Tablet | 0.78 | 8.87% | 28.61 | 0.29 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | 8.79 | 100.00% | -- | 0.35 | 0.41 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | maximum | 0.38 | minimum | 0.29 |
| -- | As per the above there are 4 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Sum of MAT value considered for price calculation | 879.00 | (Rs. in lak | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Sum of PTR per unit considered for price calculation | 2.07 | -- | -- |
-- | -- |
||||||
| -- | Number of Packs considered | 6 | -- | -- |
||||||||
| -- | Average PTR | 0.35 | -- | -- |
||||||||
| -- | Add : 16% Retailer Margin | 0.06 | -- | -- |
||||||||
| -- | Ceiling Price (without local taxes) | 0.41 | -- | -- |
||||||||
| -- | % Reduction with compared to Highest Price | 7.89% | -- | -- |
||||||||
| -- | -- | -- | -- | -- | -- | -- |
||||||
| -- | WPI increase on 1 April, 2014 | 6.32% | -- | -- |
||||||||
| -- | Ceiling Price after WPI Adjustment | 0.44 | -- | -- |
||||||||
| -- | WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
| -- | Ceiling Price after WPI Adjustment | 0.46 | -- |
|||||||||
Source of data: Pharma Trac and company
| NLEM Unique No. | Composition as per NLEM | PACK_DESC | BRANDS | Company | Strength | Pack size | Unit | MAT Sep’14 Value | MAT% | PTR Sep’14 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.2.2.8.1.2 | Metronidazole Tablet 400 mg | FLAGYL 400 MG TABLET 15 | -- | ABBOTT HEALTHCARE PVT. LTD | 400 | 15 | Tablet | 14.46 | 25.86% | 9.78 | 0.65 | -- |
| -- | Metronidazole Tablet 400 mg | METRON FORTE 400 MG TABLET 10 | -- | ALKEM LABORATORIES LTD. | 400 | 10 | Tablet | 2.70 | 4.82% | 6.40 | 0.64 | -- |
| -- | Metronidazole Tablet 400 mg | METRON 400 MG TABLET 10 | -- | ALKEM LABORATORIES LTD. | 400 | 10 | Tablet | 0.75 | 1.34% | 6.40 | 0.64 | -- |
| -- | Metronidazole Tablet 400 mg | ARISTOGYL 400 MG TABLET 10 | -- | ARISTO PHARMACEUTICALS PVT.LT | 400 | 10 | Tablet | 0.22 | 0.40% | 6.47 | 0.65 | -- |
| -- | Metronidazole Tablet 400 mg | METGYL 400 MG TABLET 100 | -- | JAGSONPAL PHARMACEUTICALS LT | 400 | 100 | Tablet | 0.15 | 0.27% | 47.00 | 0.47 | -- |
| -- | Metronidazole Tablet 400 mg | METROGYL 400 MG TABLET 15 | -- | JB CHEMICALS | 400 | 15 | Tablet | 37.64 | 67.31% | 9.78 | 0.65 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | 55.9 | 100.00% | -- | 0.65 | 0.75 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | maximum | 0.65 | minimum | 0.64 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | As per the above there are 3 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Sum of MAT value considered for price calculation | 5,554.00 | (Rs. in lak | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Sum of PTR per unit considered for price calculation | 2.58 | -- | -- |
-- | -- |
||||||
| -- | Number of Packs considered | 4 | -- | -- | -- |
|||||||
| -- | Average PTR | 0.65 | -- | -- | -- |
|||||||
| -- | Add : 16% Retailer Margin | 0.10 | -- | -- | -- |
|||||||
| -- | Ceiling Price (without local taxes) | 0.75 | -- | -- | -- |
|||||||
| -- | % Reduction with compared to Highest Price | 0.00% | -- | -- | -- |
|||||||
| -- | -- | -- | -- | -- | -- | -- | -- |
|||||
| -- | WPI increase on 1 April, 2014 | 6.32% | -- | -- | -- |
|||||||
| -- | Ceiling Price after WPI Adjustment | 0.80 | -- | -- | -- |
|||||||
| -- | WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
| -- | Ceiling Price after WPI Adjustment | 0.83 | -- |
|||||||||
Source of data: Pharma Trac and companies
| NLEM Unique No. | Composition as per NLEM | PACK_DESC | BRANDS | Company | Strength | Pack size | Unit | MAT Sep’14 Value | MAT% | PTR Sep’14 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | Metronidazole Injection 500mg/100ml | METRONIDAZOLE (ALBERT) 500 MG INFUSION 100 ML | -- | ALBERT DAVID | 500 | 100 | ML | 0.13 | 0.68% | 10.25 | 0.10 | -- |
| -- | Metronidazole Injection 500mg/100ml | METRON 500 MG INFUSION 100 ML | -- | ALKEM LABORATORIES LTD. | 500 | 100 | ML | 4.52 | 24.12% | 10.26 | 0.10 | -- |
| -- | Metronidazole Injection 500mg/100ml | METRIS 500 MG INFUSION 100 ML | -- | CLARIS LIFESCIENCES LIMITED | 500 | 100 | ML | 0.90 | 4.79% | 9.50 | 0.10 | -- |
| -- | Metronidazole Injection 500mg/100ml | Alemetro I V Inj 100 ml | -- | Alembic | 500 | 100 | ML | 0.23 | 1.23% | 10.36 | 0.10 | -- |
| -- | Metronidazole Injection 500mg/100ml | METROGYL IV 500 MG INFUSION 100 M | -- | JB CHEMICALS | 500 | 100 | ML | 12.48 | 66.63% | 10.99 | 0.11 | -- |
| -- | Metronidazole Injection 500mg/100ml | Metronidazole injection IP 100 ml | -- | Rusoma Lab | 500 | 100 | ML | 0.36 | 1.93% | 11.00 | 0.11 | -- |
| -- | Metronidazole Injection 500mg/100ml | Restrogyl injection 100 ml | -- | Rusoma Lab | 500 | 100 | ML | 0.12 | 0.62% | 11.00 | 0.11 | -- |
| -- | -- | -- | -- | -- | -- | -- | -- | 18.7 | 100.00% | -- | 0.11 | 0.13 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | maximum | 0.11 | minimum | 0.10 |
| -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | As per the above there are 6 companies consisting of Market Share of 1% & Above | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| -- | Sum of MAT value considered for price calculation | 1,860.00 | (Rs. in lak | -- | -- | -- | -- | -- | -- | -- | ||
| -- | Sum of PTR per unit considered for price calculation | 0.63 | -- | -- |
-- | -- |
||||||
| -- | Number of Packs considered | 6 | -- | -- | -- |
|||||||
| -- | Average PTR | 0.11 | -- | -- | -- |
|||||||
| -- | Add : 16% Retailer Margin | 0.02 | -- | -- | -- |
|||||||
| -- | Ceiling Price (without local taxes) | 0.13 | -- | -- | -- |
|||||||
| -- | % Reduction with compared to Highest Price | 0.00% | -- | -- | -- |
|||||||
| -- | -- | -- | -- | -- | -- | -- | -- |
|||||
| -- | WPI increase on 1 April, 2014 | 6.32% | -- | -- | -- |
|||||||
| -- | Ceiling Price after WPI Adjustment | 0.14 | -- | -- | -- |
|||||||
| -- | WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
| -- | Ceiling Price after WPI Adjustment | 0.15 | -- |
|||||||||
| S.No. | Formulation | Route of Administration | Strengths | Companies considered for working with more than 1% MAT value | As per Pharma Trac | Company’s Reply | MAT Value | DPCO, 1995 S.O. No. | Date | Quantity | Ceiling Price | C.P for 1 unit | Derived PTR as per DPCO 1995 | Company submitted data | PTR considered at present | Revised C.P. With Retailer Margin @ 16% | Revised C.P. W.e.f. 01.04.2014 after allowing WPI for 2013 @ 6.32% | Revised C.P. W.e.f. 01.04.2015 after allowing WPI for 2014 @ 3.849% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ibuprofen | Tablet | 200mg | Abbott | Abbott | Abbott provided data | 23,006,484 | 3786(E) | 20.12.2013 | 10 | 3.77 | 0.38 | 0.35 | 0.3407 (Sept.2014) | 0.3407 | 0.40 | 0.43 | 0.45 |
| 2 | Ibuprofen | Tablet | 400mg | Abbott | Abbott | Abbott provided data | 178,361,974 | 3786(E) | 20.12.2013 | 10 | 6.45 | 0.65 | 0.59 | 0.58 (Sept.2014) | 0.58 | 0.67 | 0.71 | 0.74 |
Last Page Updated: 10-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)